Huang is a postdoctoral fellow of medicine at Cedars-Sinai. His research focuses on network analyses of metastatic prostate cancer with focus on molecular mechanisms underlying osteoblastic and osteolytic related gene expression by human prostate cancer cell lines.
Josson studies the role of microRNA in prostate cancer progression. She determines the role of specific oncogenic and tumor suppressive microRNA in the regulation of the tumor-stroma interaction in prostate cancer and in bone metastasis.
Wang is an associate professor of medicine at both Cedars-Sinai and UCLA. He characterizes the stem cell phenotypes in prostate cancer cells, defines the fusion between prostate cancer epithelial and prostate stromal cells, and explores the use of stem cells as therapeutic targeting agent.
Wu discovered an exciting novel therapeutic target, monoamine oxidase inhibitor (MAO), and also characterizes the mechanism of hypoxia regulating MAO expression and near-infrared dye uptake in prostate cancer cells.
Zhau is a professor of medicine at Cedars-Sinai. Her research interest is cancer plasticity and EMT. She developed multiplex imaging technology at the single cell level for cancer prognosis, diagnosis, and treatment follow-up, and for gene expression profiling of CTC in prostate cancer cell models and clinical specimens.